Velcrin-induced selective cleavage of tRNALeu(TAA) by SLFN12 causes cancer cell death.
Nat Chem Biol
; 19(3): 301-310, 2023 03.
Article
em En
| MEDLINE
| ID: mdl-36302897
ABSTRACT
Velcrin compounds kill cancer cells expressing high levels of phosphodiesterase 3A (PDE3A) and Schlafen family member 12 (SLFN12) by inducing complex formation between these two proteins, but the mechanism of cancer cell killing by the PDE3A-SLFN12 complex is not fully understood. Here, we report that the physiological substrate of SLFN12 RNase is tRNALeu(TAA). SLFN12 selectively digests tRNALeu(TAA), and velcrin treatment promotes the cleavage of tRNALeu(TAA) by inducing PDE3A-SLFN12 complex formation in vitro. We found that distinct sequences in the variable loop and acceptor stem of tRNALeu(TAA) are required for substrate digestion. Velcrin treatment of sensitive cells results in downregulation of tRNALeu(TAA), ribosome pausing at Leu-TTA codons and global inhibition of protein synthesis. Velcrin-induced cleavage of tRNALeu(TAA) by SLFN12 and the concomitant global inhibition of protein synthesis thus define a new mechanism of apoptosis initiation.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
RNA de Transferência de Leucina
/
Neoplasias
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article